tiprankstipranks

Stephen Hoge Insider Profile

11 Followers
Stephen Hoge, President at Moderna, holds 1.60M shares in Moderna (Ticker: MRNA), holds ― shares in Axcella Health (Ticker: AXLA).
tipranks
Stephen Hoge

Stephen Hoge
Moderna (MRNA)
President

Not Ranked
Stephen Hoge has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$63M
100.00%
A breakdown of Stephen Hoge's holdings

Insider Roles

Moderna
(MRNA)
President
Roles that Stephen Hoge holds in companies

Most Profitable Insider Trade

Stock:
Moderna
(MRNA)
Rating:Informative Sell
Date:Jun 27, 2022 - Jun 27, 2023
Return:+16.90%
The most profitable trade made by Stephen Hoge

Stephen Hoge's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Moderna
Dec 04, 2024
President
Uninformative Buy
14.92K
$63.02M
AXLA
Axcella Health
List of latest transactions for each holding click on a transaction to see Stephen Hoge's performance on stock

Stephen Hoge insider profile FAQ

What is the percentage of profitable transactions made by Stephen Hoge?
The percentage of profitable transactions made by Stephen Hoge is ―.
    What is the average return per transaction made by Stephen Hoge?
    The average return per transaction made by Stephen Hoge is ―.
      What stocks does Stephen Hoge hold?
      Stephen Hoge holds: MRNA, AXLA stocks.
        What was Stephen Hoge’s latest transaction?
        Stephen Hoge latest transaction was an Uninformative Buy of $14.92K.
          What was Stephen Hoge's most profitable transaction?
          Stephen Hoge’s most profitable transaction was an Informative Sell of MRNA stock on June 27, 2022. The return on the trade was 16.90%.
            What is Stephen Hoge's role in Moderna?
            Stephen Hoge's role in Moderna is President.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.